Publications 2013

  • Afshar-Oromieh A., Malcher A., Eder M., Eisenhut M., Linart H.G., Hadaschik B.A., Holland-Letz T., Giesel F.L., Kratochwil C., Haufe S., Haberkorn U., Zechmann C.M.:  PET imaging with a [(68)Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur.J.Nucl.Med.Mol.Imag. 40 (4) 486-495, 2013.
  • Amarteifio E., Wormsbecher S., Demirel S., Krix M., Braun S., Rehnitz C., Delorme S., Kauczor H.U., Weber M.A.:  Assessment of skeletal muscle microcirculation in type 2 diabetes mellitus using dynamic contrast-enhanced ultrasound: a pilot study. Diab.Vasc.Dis.Res. 10 (5) 468-470, 2013.
  • Amarteifio E., Krix M., Wormsbecher S., Demirel S., Braun S., Delorme S., Kauczor H.U., Böckler D., Weber M.A.:  Dynamic contrast-enhanced ultrasound for assessment of therapy effects on skeletal muscle microcirculation in peripheral arterial disease: pilot study. Eur.J.Radiol. 82 (4) 640-646, 2013.
  • Baccelli I., Schneeweiss A., Riethdorf S., Stenzinger A., Schillert A., Vogel V., Klein C., Saini M., Bäuerle T., Wallwiener M., Holland-Letz T., Höfner T., Sprick M., Scharpff M., Marme F., Sinn H.P., Pantel K., Weichert W., Trumpp A.:  Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat.Biotechnol. 31 (6) 539-544, 2013.
  • Bauman G., Puderbach M., Heimann T., Kopp-Schneider A., Fritzsching E., Mall M.A., Eichinger M.:  Validation of Fourier decomposition MRI with dynamic contrast-enhanced MRI using visual and automated scoring of pulmonary perfusion in young cystic fibrosis patients. Eur.J.Radiol. 82 (12) 2371-2377, 2013.
  • Bäuerle T., Seyler L., Münter M., Jensen A., Brand K., Fritzsche K.H., Kopp-Schneider A., Schüssler M., Schlemmer H.P., Stieltjes B., Ganten M.:  Diffusion-weighted imaging in rectal carcinoma patients without and after chemoradiotherapy: a comparative study with histology.  Eur.J.Radiol. 82 (3) 444-452, 2013.
  • Binder H., Benner A., Bullinger L., Schumacher M.:  Tailoring sparse multivariable regression techniques for prognostic single-nucleotide polymorphism signatures. Stat.Med. 32 (10) 1778-1791, 2013.
  • Bochtler T., Stölzel F., Heilig C.E., Kunz C., Mohr B., Jauch A., Janssen J.W., Kramer M., Benner A., Bornhäuser M., Ho A.D., Ehninger G., Schaich M., Krämer A.:  Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemia. J.Clin.Oncol. 31 (31) 3898-3905, 2013.
  • Claus R., Pfeifer D., Almstedt M., Zucknick M., Hackanson B., Plass C., Lübbert M.:  Decitabine induces very early in vivo DNA methylation changes in blasts from patients with acute myeloid leukemia. Leukem.Res. 37 (2) 190-196, 2013.
  • Clothier R., Gomez-Lechon M.J., Kinsner-Ovaskainen A., Kopp-Schneider A., O'Connor J.E., Prieto P., Stanzel S.:  Comparative analysis of eight cytotoxicity assays evaluated within the ACuteTox Project. Toxicol.in Vitro 27 (4) 1347-1356, 2013.
  • Combs S.E., Edler L., Rausch R., Welzel T., Wick W., Debus J.:  Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma. Acta Oncol. 52 (1) 147-152, 2013.
  • Cuk K., Zucknick M., Madhavan D., Schott S., Golatta M., Heil J., Marme F., Turchinovich A., Sinn P., Sohn C., Junkermann H., Schneeweiss A., Burwinkel B.:  Plasma microRNA panel for minimally invasive detection of breast cancer. PLoS_ONE 8 (10) e76729, 2013.
  • Cuk K., Zucknick M., Heil J., Madhavan D., Schott S., Turchinovich A., Arlt D., Rath M., Sohn C., Benner A., Junkermann H., Schneeweiss A., Burwinkel B.:  Circulating microRNAs in plasma as early detection markers for breast cancer. Int.J.Cancer 132 (7) 1602-1612, 2013.
  • Dietrich S., Falk C.S., Benner A., Karamustafa S., Hahn E., Andrulis M., Hegenbart U., Ho A.D., Dreger P., Luft T.:  Endothelial vulnerability and endothelial damage are associated with risk of Graft-versus-host disease and response to steroid treatment. Biol.Blood Marrow Transplant. 19 (1) 22-27, 2013.
  • Dorne J.L., Doerge D.R., Vandenbroeck M., Fink-Gremmels J., Mennes W., Knutsen H.K., Vernazza F., Castle L., Edler L., Benford D.:  Recent advances in the risk assessment of melamine and cyanuric acid in animal feed. Toxicol.Appl.Pharmacol. 270 (3) 218-229, 2013.
  • Dubuc A.M., Remke M., Korshunov A., Northcott P.A., Zhan S.H., Mendez-Lago M., Kool M., Jones D.T., Unterberger A., Morrissy A.S., Shih D., Peacock J., Ramaswamy V., Rolider A., Wang X., Witt H., Hielscher T., Hawkins C., Vibhakar R., Croul S., Rutka J.T., Weiss W.A., Jones S.J., Eberhart C.G., Marra M.A., Pfister S.M., Taylor M.D.:  Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. Acta Neuropathol. 125 (3) 373-384, 2013.
  • Dutruel C., Bergmann F., Rooman I., Zucknick M., Weichenhan D., Geiselhart L., Kaffenberger T., Rachakonda P.S., Bauer A., Giese N., Hong C., Xie H., Costello J.F., Hoheisel J., Kumar R., Rehli M., Schirmacher P., Werner J., Plass C., Popanda O., Schmezer P.:  Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development. Oncogene (epub) , 2013.
  • Edler L. as member of the EFSA Panel on Contaminants in the Food Chain (CONTAM): Scientific opinion - Guidance on methodological principles and scientific methods to be taken into account when establishing Reference Points for Action (RPAs) for non-allowed pharmacologically active substances present in food of animal origin. EFSA J. 11 (4) 3195 (24p.), 2013.
  • Edler L. as member of the EFSA Panel on Contaminants in the Food Chain (CONTAM): Scientific opinion on risks for animal and public health related to the presence of nivalenol in food and feed. EFSA J. 11 (6) 3262 (119p.), 2013.
  • Edler L. as member of the EFSA Panel on Contaminants in the Food Chain (CONTAM): Scientific opinion on tropane alkaloids in food and feed. EFSA J. 11 (10) 3386 (113p.), 2013.
  • Edler L. as member of the EFSA Panel on Contaminants in the Food Chain (CONTAM): Scientific opinion on the risk for public and animal health related to the presence of sterigmatocystin in food and feed. EFSA J. 11 (6) 3254 (81p.), 2013.
  • Edler L. as member of the EFSA Panel on Contaminants in the Food Chain (CONTAM): Scientific opinion. Statement on the risks for public health related to a possible increase of the maximum level of deoxynivalenol for certain semi-processed cereal products. EFSA J. 11 (12) 3490 (56p.), 2013.
  • Edler L., Hart A., Greaves P., Carthew P., Coulet M., Boobis A., Williams G.M., Smith B.:  Selection of appropriate tumour data sets for Benchmark dose modelling (BMD) and derivation of a margin of exposure (MoE) for substances that are genotoxic and carcinogenic: consderations of biological relevance of tumour type, data quality and uncertainty assessment. Food Chem.Toxicol. (epub) , 2013.
  • Forchmann A., Malzkorn B., Reifenberger G., Engel N., Felsberg J., Monoranu C., Reifenberger G., Schüller U., Capper D., Jones D., Hovestadt V., Sill M., Korshunov A., Schick M., Lindenberg K., Schweizer L., Sahm F., Reuss D., Koelsche C., Schittenhelm J., Hartmann C., Mittelbronn M., Wick W., Mende C.H., Debus J., Witt O., Pfister S., Deimling A.v.:  58th Annual Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN), Gottingen, Germany, September 11-14, 2013 Abstracts. Clin.Neuropathol. 32 (5) 413-451, 2013.
  • Funke V., Lehmann-Koch J., Bickeböller M., Benner A., Tagscherer K.E., Grund K., Pfeifer M., Herpel E., Schirmacher P., Chang-Claude J., Brenner H., Hoffmeister M., Roth W.:  The PEA-15/PED protein regulates cellular survival and invasiveness in colorectal carcinomas. Cancer Lett. 335 (2) 431-440, 2013.
  • Ganten M.K., Schüssler M., Bäuerle T., Münter M., Schlemmer H.P., Jensen A., Brand K., Dück M., Dinkel J., Kopp-Schneider A., Fritzsche K., Stieltjes B.:  The role of perfusion effects in monitoring of chemoradiotherapy of rectal carcinoma using diffusion-weighted imaging. Cancer Imag. 13 (4) 548-556, 2013.
  • Garding A., Bhattacharya N., Claus R., Ruppel M., Tschuch C., Filarsky K., Idler I., Zucknick M., Caudron-Herger M., Oakes C., Fleig V., Keklikoglou I., Allegra D., Serra L., Thakurela S., Tiwari V., Weichenhan D., Benner A., Radlwimmer B., Zentgraf H., Wiemann S., Rippe K., Plass C., Döhner H., Lichter P., Stilgenbauer S., Mertens D.:  Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In cis downregulation of a gene cluster that targets NF-kB. PLoS_GENET. 9 (4) e1003373, 2013.
  • Goeppert B., Frauenschuh L., Zucknick M., Stenzinger A., Andrulis M., Klauschen F., Joehrens K., Warth A., Renner M., Mehrabi A., Hafezi M., Thelen A., Schirmacher P., Weichert W.:  Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer. Br.J.Cancer 109 (2665) 2674, 2013.
  • Gogolin S., Batra R., Harder N., Ehemann V., Paffhausen T., Diessl N., Sagulenko V., Benner A., Gade S., Nolte I., Rohr K., König R., Westermann F.:  MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cells. Cancer Lett. 331 (1) 35-45, 2013.
  • Hien M.D., Rauch H., Lichtenberg A., De Simone R., Weimer M., Ponta O., Rosendal C.:  Real-time three-dimensional transesophageal echocardiography: improvements in intraoperative mitral valve imaging. Anesth.Analg. 116 (2) 287-295, 2013.
  • Horvath Z., Ambrus A., Meszaros L., Braun S.:  Characterization of distribution of pesticide residues in crop units. J.Environ.Sci.Health.B 48 (8) 615-625, 2013.
  • Hönsch H.P., Rölofs H.M.J., Edler L., Kirch W., Peters W.H.M.:  Disparities of conjugating protective enzyme activities in the colon of patients with adenomas and carcinomas. World J.Gastroenterol. 19 (36) 6020-6025, 2013.
  • Hüllein J., Jethwa A., Stolz T., Blume C., Sellner L., Sill M., Langer C., Jauch A., Paruzynski A., von Kalle C., Schmidt M., Glimm H., Zenz T.:  Next-generation sequencing of cancer consensus genes in lymphoma. Leuk.Lymphoma 54 (8) 1831-1835, 2013.
  • Jethwa A., Hüllein J., Stolz T., Blume C., Sellner L., Jauch A., Sill M., Kater A.P., Te Raa G.D., Geisler C., van Oers M., Dietrich S., Dreger P., Ho A.D., Paruzynski A., Schmidt M., von Kalle C., Glimm H., Zenz T.:  Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia. Br.J.Haematol. 163 (4) 496-500, 2013.
  • Kinsner-Ovaskainen A., Prieto P., Stanzel S., Kopp-Schneider A.:  Selection of test methods to be included in a testing strategy to predict acute oral toxicity: An approach based on statistical analysis of data collected in phase 1 of the ACuteTox project. Toxicol.in Vitro 27 (4) 1377-1394, 2013.
  • Kopp-Schneider A., Prieto P., Kinsner-Ovaskainen A., Stanzel S.:  Design of a testing strategy using non-animal based test methods: Lessons learnt from the ACuteTox project. Toxicol.in Vitro 27 (4) 1395-1401, 2013.
  • Kostareli E., Holzinger D., Bogatyrova O., Hielscher T., Wichmann G., Keck M., Lahrmann B., Grabe N., Flechtenmacher C., Schmidt C.R., Seiwert T., Dyckhoff G., Dietz A., Höfler D., Pawlita M., Benner A., Bosch F.X., Plinkert P., Plass C., Weichenhan D., Hess J.:  HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas. J.Clin.Invest. 123 (6) 2488-2501, 2013.
  • Kuhmann C., Li C., Kloor M., Salou M., Weigel C., Schmidt C.R., Ng L.W., Tsui W.W., Leung S.Y., Yuen S.T., Becker N., Weichenhan D., Plass C., Schmezer P., Chan T.L., Popanda O.:  Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer. Hum.Mol.Genet. (epub), 2013. 
  • Lambert S.R., Witt H., Hovestadt V., Zucknick M., Kool M., Pearson D.M., Korshunov A., Ryzhova M., Ichimura K., Jabado N., Fontebasso A.M., Lichter P., Pfister S.M., Collins V.P., Jones D.T.:  Differential expression and methylation of brain developmental genes define location-specific subsets of pilocytic astrocytoma. Acta Neuropathol. 126 (2) 291-301, 2013.
  • Lehners N., Schnitzler P., Geis S., Puthenparambil J., Benz M.A., Alber B., Luft T., Dreger P., Eisenbach C., Kunz C., Benner A., Buchholz U., Aichinger E., Frank U., Heeg K., Ho A.D., Egerer G.:  Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit. Bone Marrow Transplant. 48 (12) 1548-1553, 2013.
  • Leprivier G., Remke M., Rotblat B., Dubuc A., Mateo A.R.F., Kool M., Agnihotri S., El-Naggar A., Yu B., Somasekharan S.P., Faubert B., Bridon G., Tognon C.E., Mathers J., Thomas R., Li A., Barokas A., Kwok B., Bowden M., Smith S., Wu X., Korshunov A., Hielscher T., Northcott P.A., Galphin J.D., Ahern G.A., Wang Y., McCabe M.G., Collins V.P., Jones R.G., Pollak M., Delattre O., Gleave M.E., Jan E., Pfister S.M., Proud C.G., Derry W.B., Taylor M.D., Sorensen P.H.:  The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell 153 (5) 1064-1079, 2013.
  • Li J., Bonifati S., Hristov G., Marttila T., Valmary-Degano S., Stanzel S., Schnölzer M., Mougin C., Aprahamian M., Grekova S.P., Raykov Z., Rommelaere J., Marchini A.:  Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas. EMBO Mol.Med. 5 (10) 1537-1555, 2013.
  • Lodrini M., Öhme I., Schröder C., Milde T., Schier M.C., Kopp-Schneider A., Schulte J.H., Fischer M., De Preter K., Pattyn F., Castoldi M., Muckenthaler M.U., Kulozik A.E., Westermann F., Witt O., Deubzer H.E.:  MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma. Nucl.Acids Res. 41 (12) 6018-6033, 2013.
  • Möhler T.M., Seckinger A., Hose D., Andrulis M., Moreaux J., Hielscher T., Willhauck-Fleckenstein M., Merling A., Bertsch U., Jauch A., Goldschmidt H., Klein B., Schwartz-Albiez R.:  The glycome of normal and malignant plasma cells. PLoS_ONE 8 (12) e83179, 2013.
  • Müller-Eschner M., Rengier F., Partovi S., Weber T.F., Kopp-Schneider A., Geisbüsch P., Kauczor H.U., Tengg-Kobligk H.v.:  Accuracy and variability of semiautomatic centerline analysis versus manual aortic measurement techniques for TEVAR. Eur.J.Vasc.Endovasc.Surg. 45 (3) 241-247, 2013.
  • Nakata S., Campos B., Bageritz J., Lorenzo Bermejo B., Becker N., Engel F., Acker T., Momma S., Herold-Mende C., Lichter P., Radlwimmer B., Goidts V.:  LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells. Brain Pathol. 23 (1) 60-72, 2013.
  • Neben K., Jauch A., Hielscher T., Hillengass J., Lehners N., Seckinger A., Granzow C., Raab M.S., Ho A.D., Goldschmidt H., Hose D.:  Progression in smoldering myeloma Is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load. J.Clin.Oncol. 31 (34) 4325-4332, 2013.
  • Oakes C.C., Claus R., Gu L., Assenov Y., Hüllein J., Zucknick M., Brocks D., Bogatyrova O., Schmidt C., Rassenti L., Kipps T.J., Mertens D., Lichter P., Döhner H., Stilgenbauer S., Byrd J.C., Zenz T., Plass C.:  Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia. Cancer Discov. (epub) , 2013.
  • Parmentier C., Truisi G., Mönks K., Stanzel S., Lukas A., Kopp-Schneider A., Alexandre E., Hewitt P., Müller S.O., Richert L.:  Transcriptomic hepatotoxicity signature of chlorpromazine after short and long-term exposure in primary human sandwich cultures. Drug Metab.Dispos. 41 (10) 1835-1842, 2013.
  • Pellagatti A., Benner A., Mills K.I., Cazzola M., Giagounidis A., Perry J., Malcovati L., Della Porta M.G., Jädersten M., Verma A., McDonald E.J., Killik S., Hellström-Lindberg E., Bullinger L., Wainscoat J.S., Boultwood J.:  Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes. J.Clin.Oncol. 31 (28) 3557-3564, 2013.
  • Prieto P., Kinsner-Ovaskainen A., Stanzel S., Albella B., Artursson P., Campillo N., Cecchelli R., Cerrato L., Diaz L., Di Consiglio E., Guerra A., Gombau L., Herrera G., Honegger P., Landry C., O'Connor J.E., Paez J.A., Quintas G., Svensson R., Turco L., Zurich M.G., Zurbano M.J., Kopp-Schneider A.:  The value of selected in vitro and in silico methods to predict acute oral toxicity in a regulatory context: Results from the European Project ACuteTox. Toxicol.in Vitro 27 (4) 1357-1376, 2013.
  • Remke M., Hering E., Gerber N.U., Kool M., Sturm D., Rickert C.H., Gerss J., Schulz S., Hielscher T., Hasselblatt M., Jeibmann A., Hans V., Ramaswamy V., Taylor M.D., Pietsch T., Rutkowski S., Korshunov A., Monoranu C.M., Frühwald M.C.:  Somatostatin receptor subtype 2 (sst2) is a potential prognostic marker and a therapeutic target in medulloblastoma. Childs Nerv.Syst. 29 (8) 1253-1262, 2013.
  • Renner M., Zurich M.G., Kopp-Schneider A.:  Stochastic time-concentration activity models for in vitro neurotoxicity. Theor.Biol.Med.Model. 10 (1) 19, 2013.
  • Rignall B., Grote K., Gavrilov A., Weimer M., Kopp-Schneider A., Krause E., Appel K.E., Buchmann A., Robertson L.W., Lehmler H.J., Kania-Korwel I., Chahoud I., Schwarz M.:  Biological and tumor-promoting effects of dioxin-like and non-dioxin-like polychlorinated biphenyls in mouse liver after single or combined treatment. Toxicol.Sci. 133 (1) 29-41, 2013.
  • Schmitt S., Hielscher T., Baldus C., Neben K., Egerer G., Hillengass J., Raab M., Hose D., Ho A.D., Bergner R., Goldschmidt H., Möhler T.M.:  Bisphosphonate treatment and renal function in 201 myeloma patients undergoing stem cell transplantation. Int.J.Hematol. 97 (6) 765-772, 2013.
  • Schröder C., Srinivasan H., Sill M., Linseisen J., Fellenberg K., Becker N., Nieters A., Hoheisel J.:  Plasma protein analysis of patients with different B-cell lymphomas using high-content antibody microarrays. Proteom.Clin.Appl. 7 (11-12) 802-812, 2013.
  • Seibold P., Hall P., Schoorf N., Nevanlinna H., Heikkinnen T., Benner A., Liu J., Schmezer P., Popanda O., Flesch-Janys D., Chang-Claude J.:  Polymorphisms in oxidative stress-related genes and mortality in breast cancer patients - Potential differential effects by radiotherapy? Breast 22 (5) 817-823, 2013.
  • Seitz H., Schmitt M., Böhmer G., Kopp-Schneider A., Müller M.:  Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2. Int.J.Cancer 132 (3) E139-E148, 2013.
  • Sellner L., Heiss C., Benner A., Raab M.S., Hillengass J., Hose D., Lehners N., Egerer G., Ho A.D., Goldschmidt H., Neben K.:  Autologous retransplantation for patients with recurrent multiple myeloma: A single-center experience with 200 patients. Cancer 119 (13) 2438-2446, 2013.
  • Shahmoradgoli M., Riazalhosseini Y., Haag D., Becker N., Hovestadt V., Heck S., Sinn H.P., Schneeweiss A., Mannherz O., Sahin O., Lichter P.:  Protein phosphatase 1, regulatory subunit 15B is a survival factor for ER-alpha-positive breast cancer. Int.J.Cancer 132 (11) 2714-2719, 2013.
  • Stanzel S., Weimer M., Kopp-Schneider A.:  Data management in large-scale collaborative toxicity studies: How to file experimental data for automated statistical analysis. Toxicol.in Vitro 27 (4) 1402-1409, 2013.
  • Valdora F., Banelli B., Stigliani S., Pfister S.M., Moretti S., Kool M., Remke M., Bai A.H., Brigati C., Hielscher T., Romani M., Servidei T., Zollo M., Cinalli G., Oberthür A., Tonini G.P., Coco S.:  Epigenetic silencing of DKK3 in medulloblastoma. Int.J.Mol.Sci. 14 (4) 7492-7505, 2013.
  • Ward A., Balwierz A., Zhang J.D., Küblbeck M., Pawitan Y., Hielscher T., Wiemann S., Sahin O.:  Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene 32 (9) 1173-1182, 2013.
  • Wei Q.X., Claus R., Hielscher T., Mertens D., Raval A., Oakes C.C., Tanner S.M., de la Chapelle A., Byrd J.C., Stilgenbauer S., Plass C.:  Germline allele-specific expression of DAPK1 in chronic lymphocytic leukemia. PLoS_ONE 8 (1) e55261, 2013.
  • Wiestler B., Capper D., Holland-Letz T., Korshunov A., von Deimling A., Pfister S.M., Platten M., Weller M., Wick W.:  ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis. Acta Neuropathol. 126 (3) 443-451, 2013.
  • Wiestler B., Claus R., Hartlieb S.A., Schliesser M.G., Weiss E.K., Hielscher T., Platten M., Dittmann L.M., Meisner C., Felsberg J., Happold C., Simon M., Nikkhah G., Papsdorf K., Steinbach J.P., Sabel M., Grimm C., Weichenhan D., Tews B., Reifenberger G., Capper D., Müller W., Plass C., Weller M., Wick W.:  Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective. Neuro-Oncol. 15 (8) 1017-1026, 2013.
  • Zurich M.G., Stanzel S., Kopp-Schneider A., Prieto P., Honegger P.:  Evaluation of aggregating brain cell cultures for the detection of acute organ-specific toxicity. Toxicol.in Vitro 27 (4) 1416-1424, 2013.

to top